Search
Contact Us   |   Sign In   |   Join
FMMC Executive Briefing: COVID-19 Return-to-Work Panel
Tell a Friend About This EventTell a Friend
FMMC Executive Briefing: COVID-19 Return-to-Work Panel

6/18/2020
When: Thursday, June 18, 2020
2:00 PM
Where: Live Webinar
United States
Contact: FMMC
(850) 270-3158


Online registration is closed.
« Go to Upcoming Event List  

 

 

Return-To-Work Panel Discussion:
Critical Workplace and Operational Updates for MedTech Manufacturers amid COVID-19

 

As many businesses transition from telework arrangements and return to full in-person operations, the FMMC will be hosting this timely webinar, designed to help medtech companies grapple with the many complicated and uncharted employment and operational issues presented by the COVID-19 pandemic. The webinar will cover a lot of waterfront, including best practices in facility re-opening procedures and safety plans, important employment and worker benefits issues, business contracts, as well as a timely update on the return of FDA inspections and other mission-critical agency activities. 


Robert Shimberg
Shareholder
Hill Ward Henderson
Blake Bevill
Division Director,Office of Medical Device and Radiological Health Ops
(Division 2),U.S. FDA
Carolyn Bruguera
VP & General Counsel
MDMA

 


Thank you to our Executive Briefing Series Sponsors!

 


 
 

 


About our Panelists

Robert Shimberg is a shareholder in Hill Ward Henderson's Litigation Group. His primary practice areas include commercial litigation, corporate compliance, cybersecuritygovernmental relations and corporate investigations. Robert is leading the firm's COVID-19 Response Team and advising clients on a number of related issues including state and local government orders, addressing a positive COVID-19 case in the workplace, contact tracing, liability-related issues and crisis management and communication. Robert has participated in a number of webinars and industry group meetings on these subjects.

Blake Bevill has been with the U.S. Food and Drug Administration since 1989. He was an Investigator for 12 years which included conducting foreign inspections. He accepted a Supervisory Investigator position in 2001. Following his participation in the FDA Leadership Program in 2005 and 2006 he became the Operations Director and worked directly with the Associate Commissioner for Regulatory Affairs and other agency leaders involved in ORA strategic planning, budgeting, and organizational initiatives. He became the Director of Compliance for Los Angeles District in 2009 and assumed the Director of Compliance position in Florida District in 2014. He is currently the Program Division Director for Division 2 within the Office of Medical Device and Radiological Health Operations. As the Director of Division 2, he leads all device inspectional and compliance activities that formerly resided in the seven District Offices of ATL-DO, CHI-DO, FLA-DO, KAN-DO, MIN-DO, NOL-DO, and SJN-DO. He graduated from Harding University with a Bachelor's Degree in Biology, Arkansas State University with a Master's of Science Degree in Biology, and completed a Senior Executive Development program at George Washington University.

Carolyn Bruguera is Vice President & General Counsel for the Medical Device Manufacturers Association (MDMA). She brings extensive experience in the management of legal affairs and compliance for medical device manufacturers. Prior to joining MDMA, Carolyn served as Vice President of Consulting Services for R-Squared Services & Solutions, Inc. (acquired by IMS Health) where she advised dozens of clients in domestic and foreign antikickback and anticorruption compliance, data privacy, Open Payments and international transparency requirements. She also served as Vice President and General Counsel to Hansen Medical, Inc., a California-based manufacturer of robotics for intravascular procedures, and to Micrus Endovascular Corporation, from its initial public offering through its acquisition by Johnson & Johnson. Before joining the medical device industry, Carolyn was a corporate and securities attorney in private practice. She received her JD from the University of California, Berkeley's Boalt Hall School of Law, and her AB, magna cum laude, from Harvard University. She speaks French fluently and is a member of the California bar. 

Association Management Software Powered by YourMembership  ::  Legal